Preclinical IV busulfan dose-finding study to induce reversible myeloablation in a non-human primate model.

by Nadim Mahmud, Amit Khanal, Simona Taioli, Emre Koca, Sujata Gaitonde, Benjamin Petro, Karen Sweiss, Lisa Halliday, Xinhe Wang, Pritesh Patel, Damiano Rondelli
Published 2018-01-01